Gsa Capital Partners LLP Puma Biotechnology, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 49,494 shares of PBYI stock, worth $134,128. This represents 0.01% of its overall portfolio holdings.

Number of Shares

49,494

Previous 189,751 73.92%

Holding current value

$134,128

Previous $619,000 79.64%

% of portfolio

0.01%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$2.25 - $4.03 $315,578 - $565,235	-140,257 Reduced 73.92%	49,494 $126,000
Q2 2024 Aug 15, 2024	BUY	$2.92 - $5.83 $6,324 - $12,627	2,166 Added 1.15%	189,751 $619,000
Q1 2024 May 03, 2024	SELL	$4.29 - $7.4 $320,686 - $553,164	-74,752 Reduced 28.49%	187,585 $994,000
Q4 2023 Feb 16, 2024	SELL	$2.23 - $4.49 $38,561 - $77,641	-17,292 Reduced 6.18%	262,337 $1.14 Million
Q3 2023 Nov 15, 2023	BUY	$2.63 - $4.09 $433,768 - $674,567	164,931 Added 143.8%	279,629 $735,000
Q2 2023 Aug 14, 2023	BUY	$2.6 - $3.58 $298,214 - $410,618	114,698 New	114,698 $404,000
Q4 2022 Feb 13, 2023	SELL	$2.12 - $5.08 $142,847 - $342,295	-67,381 Reduced 48.02%	72,940 $309,000
Q3 2022 Nov 14, 2022	BUY	$2.27 - $3.84 $162,468 - $274,836	71,572 Added 104.11%	140,321 $333,000
Q2 2022 Aug 09, 2022	SELL	$1.64 - $3.3 $115,118 - $231,640	-70,194 Reduced 50.52%	68,749 $196,000
Q1 2022 May 11, 2022	BUY	$2.13 - $3.24 $295,948 - $450,175	138,943 New	138,943 $400,000
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $245,214 - $566,143	-86,040 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.63 - $9.39 $471,757 - $668,145	71,155 Added 478.03%	86,040 $603,000
Q2 2021 Aug 05, 2021	BUY	$8.98 - $11.6 $133,667 - $172,666	14,885 New	14,885 $137,000
Q1 2020 May 12, 2020	SELL	$6.28 - $14.57 $525,548 - $1.22 Million	-83,686 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$6.5 - $10.73 $384,709 - $635,065	59,186 Added 241.58%	83,686 $732,000
Q3 2019 Nov 12, 2019	SELL	$8.75 - $12.85 $45,657 - $67,051	-5,218 Reduced 17.56%	24,500 $264,000
Q2 2019 Aug 06, 2019	BUY	$12.3 - $35.76 $286,380 - $832,600	23,283 Added 361.82%	29,718 $378,000
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $133,654 - $272,650	6,435 New	6,435 $250,000

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $123M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Puma Biotechnology, Inc. Transaction History